Coldrif cough syrup banned in Delhi
New Delhi: In a move to safeguard public health, the Delhi government has banned the sale, purchase and distribution of Coldrif cough syrup after it was declared not of standard quality by the Government Analyst, Drug Testing Laboratory, Food and Drugs Administration, Madhya Pradesh.
"Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate Syrup), Batch Number: SR-13, Manufacturing date: May/2025, Expiry date: APR/2027, Manufacturer: Sresan Pharmaceutical Manufacturer, No 787, Bangalore Highways, Sunguvanchatram (Mathura), Kancheepuram Diastrict, 612106 of Tamil Nadu," the order stated.
The aforementioned drug formulation is reported to be adulterated, as it contains Diethylene Glycol (46.28% w/v), which makes the drug formulation injurious to health.
All stakeholders are directed to refrain from dealing in said cough syrup with immediate effect and not to indulge in purchase, sale and distribution of this cough syrup.
General public is also sensitized to abstain from using this cough syrup.
Read also: Contaminated Cough syrup tragedy: Sresen Pharma owner remanded in 10-day police custody
Next Story